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Abstract
Background: Live donor kidney transplantation (LDKT), an optimal therapy for many patients with end-stage
kidney disease, is underutilized, particularly by African Americans. Potential recipient difficulties initiating and
sustaining conversations about LDKT, identifying willing and medically eligible donors, and potential donors’
logistical and financial hurdles have been cited as potential contributors to race disparities in LDKT. Few
interventions specifically targeting these factors have been tested.
Methods/Design: We report the protocol of the Talking about Living Kidney Donation Support (TALKS) study, a
study designed to evaluate the effectiveness of behavioral, educational and financial assistance interventions to
improve access to LDKT among African Americans on the deceased donor kidney transplant recipient waiting list.
We adapted a previously tested educational and social worker intervention shown to improve consideration and
pursuit of LDKT among patients and their family members for its use among patients on the kidney transplant
waiting list. We also developed a financial assistance intervention to help potential donors overcome logistical and
financial challenges they might face during the pursuit of live kidney donation. We will evaluate the effectiveness of
these interventions by conducting a randomized controlled trial in which patients on the deceased donor waiting
list receive 1) usual care while on the transplant waiting list, 2) the educational and social worker intervention, or 3)
the educational and social worker intervention plus the option of participating in the financial assistance program.
The primary outcome of the randomized controlled trial will measure potential recipients’ live kidney donor
activation (a composite rate of live donor inquiries, completed new live donor evaluations, or live kidney donation)
at 1 year.
Discussion: The TALKS study will rigorously assess the effectiveness of promising interventions to reduce race
disparities in LDKT.
Trial registration: NCT02369354.
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Background
Live donor kidney transplantation (LDKT) represents an
optimal therapy for many patients with end-stage kidney
disease, and it is associated with substantially improved
quality of life and survival compared to dialysis [1–3].
However, African Americans have been persistently and
substantially less likely to receive LDKT when compared
to Whites [4]. Numerous factors ranging from recipient
difficulties initiating and completing transplant evalua-
tions [5–7] to difficulties identifying donors [8, 9], and
donor difficulties completing medical evaluations have
been cited as contributors to race disparities in LDKT
[10]. To date, however, few interventions specifically tar-
geting factors that could hinder African Americans from
obtaining LDKT have been tested.
The process of obtaining LDKT requires that potential
recipients and donors are able to overcome several pos-
sible communication and logistical challenges, some of
which may affect African Americans disproportionately
and contribute to their lower rates of LDKT compared
to Whites. For instance, as a critical first step in the
process, patients with kidney disease, their families, and
their physicians must engage in discussions about live
donor kidney transplantation. Patient-physician discus-
sions about LDKT are needed to establish whether
LDKT is a viable and/or desirable treatment option for
potential recipients, and discussions are needed to en-
sure that potential recipients understand the risks and
benefits of LDKT. Family-physician discussions are also
important in helping family members (who not only help
potential recipients make informed treatment decisions
but who also could serve as potential donors) under-
stand the process of LDKT and associated risks and ben-
efits. Discussions occurring within families about LDKT
help families establish whether it is possible to identify
willing and medically eligible live donors, and they help
families discuss numerous considerations, including the
potential psychological, physical, and financial strains of
LDKT on family health and priorities. Studies have
shown that even when African American patients want
to obtain LDKT, they engage in discussions about LDKT
with their physicians and their family members at sub-
optimal rates [11]. African Americans are also less likely
than Whites to report they know about transplant prior
to initiating dialysis [12, 13], and they cite numerous
barriers to discussing LDKT, including their discomfort
with initiating discussions, concerns about burdening
family members, and their uncertainty regarding the ap-
propriate timing for initiating discussions [14]. Once dis-
cussions have occurred, patients and their potential
donors must consider numerous additional logistical and
financial demands placed on potential donors during the
LDKT process. For instance, potential donors may re-
quire childcare or travel to transplant centers during the
evaluation process, and they may also require unpaid
time away from work. Evidence suggests African Ameri-
cans may be more sensitive than Whites to logistical and
financial barriers to LDKT [15–17].
African Americans who are on the deceased donor
kidney transplant waiting list have already overcome
many barriers to seeking kidney transplants [5, 18].
However, communication, logistical and financial bar-
riers may prevent them from pursuing LDKT while wait-
ing for a deceased donor kidney. Evidence suggests
interventions employing behavioral support personnel
such as transplant social workers to help patients con-
sider LDKT, discuss LDKT with their physicians and
families, and overcome logistical barriers to considering
or pursuing LDKT could facilitate African Americans’
consideration of LDKT [14, 19, 20]. Donor financial
assistance programs such as the National Living
Donor Assistance Center program (NLDAC) (https://
www.livingdonorassistance.org/default.aspx), [21] could
also help African Americans overcome financial barriers
to LDKT. However, studies have not been performed to
determine whether these interventions can be employed
to improve African Americans’ access to LDKT.
We describe the protocol for a randomized controlled
trial designed to study the effectiveness of behavioral,
educational and financial assistance interventions to im-
prove access to LDKT among African Americans on the
deceased donor kidney transplant waiting list.
Methods/ Design
Overview
The Talking about Living Kidney Donation Support
(TALKS) study is a randomized controlled trial designed
to test the incremental effectiveness of (1) a culturally
sensitive educational and behavioral social worker inter-
vention and (2) a live donor financial assistance inter-
vention to improve potential kidney recipient activation
(i.e., discussions with physicians and family about LDKT)
and live kidney donation among African American
patients on the deceased donor kidney transplant
waiting list at Duke University Medical Center. We
adapted the previously developed Talking About Live
Kidney Donation (TALK) Social Worker protocol [22]
for use among transplant patients on the deceased
donor kidney waiting list and developed a live donor
financial assistance program. These interventions were
designed to overcome communication, logistical, and
financial barriers to LDKT (Table 1). The protocol
was approved by the Duke University School of Medicine
Institutional Review Board.
TALK Social Worker Intervention
The Talking about Live Kidney Donation Social Worker
Intervention (TALK SWI) was previously developed to
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improve potential recipients’ pre-emptive activation to-
ward LDKT among patients with chronic kidney disease
who had not yet developed kidney failure [20, 22]. TALK
SWI is a culturally sensitive theory-based intervention,
developed in collaboration with a behavioral psycholo-
gist, transplant nephrologists, transplant surgeons, trans-
plant social workers, patient advocacy experts from the
National Kidney Foundation of Maryland, and with the
input from patients and families with CKD and LDKT
experience. It consists of an educational booklet and
video coupled with a social worker-led brief behavioral
support intervention to help patients and their families
overcome barriers to considering and pursuing LDKT.
In a recent randomized controlled trial, the TALK SWI
was effective in activating patients to consider and pur-
sue LDKT, including their increased engagement in
LDKT discussions, their completion of LDKT medical
evaluations, and their identification of potential live do-
nors [19]. TALK SWI directly addresses many concerns
previously identified among African American patients
and families considering LDKT [14] (Table 1).
TALK SWI education The TALK SWI educational
component consists of a 20-min video and booklet that
are designed for patients and their families to review
alone or together prior to a visit with the TALK Social
Worker. The video features minority and non-minority
patients who have undergone LDKT and their family
members discussing their experiences with considering
LDKT as a treatment option from the recipient and
donor perspectives, as well as health care providers
(transplant surgeon, transplant nephrologist, transplant
social worker) citing key factors patients and families
should consider when contemplating LDKT. It also dir-
ectly addresses concerns that may pose specific barriers
to LDKT for African Americans, including mistrust or
fear of the LDKT process, difficulties discussing LDKT,
and financial considerations related to pursuing LDKT
(Table 2). The educational booklet provides a synopsis of
the LDKT process from recipient and donor perspec-
tives. It also includes a listing of publicly available re-
sources from which further information about the
LDKT evaluation, transplant, and donation process, clin-
ical risks with LDKT, and financial issues related to
LDKT can be obtained. To assist patients and family
members with initiating LDKT discussions or addressing
complex issues during LDKT discussions (e.g., donor co-
ercion), the booklet also presents several ‘model conver-
sations’ presenting examples on how to initiate and
sustain LDKT discussions. The TALK SWI booklet and
video were screened to ensure their appropriateness for
all persons considering LDKT, including minority and
non-minority persons with low (i.e. 4th grade) reading
level and low health literacy.
TALK SWI behavioral support The behavioral support
component is a protocol-driven individual and family-
based social intervention applying a Social Construction-
based Family Problem Solving theoretical framework
[23–25]. According to this framework, families are prob-
lem solving units whose optimal structure for confront-
ing problems potentially affecting all group members,
such as ESRD and LDKT, is achieved when a neutral au-
thority figure is designated as the mediator for relaying
messages between all members and encouraging open
channels of communication to enable each member to
contribute to the problem’s resolution, ultimately enhan-
cing group satisfaction. The protocol specifies that the
Table 1 Proposed mechanisms through which interventions
lead to greater pursuit of LDKT and live kidney donation among
African Americans on the deceased donor kidney transplant
waiting list
Barrier to LDKT Proposed mechanisms
Educational and social worker support
Knowledge barriers • Educational video and booklet introduce
patients and their families to LDKT
• Social worker refers patient to health care
professionals able to discuss risks with




family, health care team
• Educational video and booklet encourage
LDKT discussions
• Social worker encourages LDKT discussions,
help patients overcome self-identified
barriers to LDKT discussions
Logistical and financial
barriers
• Social worker provides patients and
families with information on existing
financial resources for recipient and
potential donor
• Social worker offers financial assistance
Intervention to assist with child care or
uncovered donor expenses related to
donor evaluation, donation, and donor
recoverya
aThose randomly assigned to financial assistance intervention only
Table 2 Barriers to LDKT identifieda by patients and family
members considering LDKT and addressed by TALK SWI
Patients Families
Difficulty initiating discussions on own Feeling overwhelmed by
patients’ disease
Concern about being misinterpreted
during LDKT discussions
Patients’ denial as barrier to
discussions
Concern about burdening family
members
Caregiver stress
Concern about guilt/ potential
donor coercion
Uncertainty about their own
health risks
Financial Concerns Financial Concerns
aIdentified in focus groups of African American and non-African American
patients with CKD [14]
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TALK Social Worker will meet with patient participants
considering LDKT during two visits. During the first
visit, the Social Worker will meet individually with the
patient participant for up to one hour to assess their
perceived barriers to completing key behaviors reflecting
their consideration and pursuit of LDKT (discussing
LDKT with their families, discussing LDKT with their
physicians, identifying a potential live donor). The TALK
Social Worker employs motivational interviewing
techniques to help patients self-identify potential bar-
riers they face toward completing LDKT and to help
patients strategize about ways they might overcome
barriers. At the time of the first visit, the TALK
Social Worker invites patients to bring adult family
members and/or friends (henceforth shortened to
“family members”) for a second visit. During the sec-
ond visit, the TALK Social Worker assesses the extent
to which previous discussions with family members
about patients’ kidney disease had occurred, the re-
sults of such conversations, whether family members
have communicated about LDKT with patients’ physi-
cians, and any barriers family members perceive
toward achieving LDKT [20, 22].
Intervention adaptation We reviewed the original
TALK SWI protocol with transplant personnel, in-
cluding a social worker, at the Duke University
Kidney and Pancreas Transplant Program and adapted
the TALK SWI into their existing workflows. Adaptation
focused on (1) ensuring the intervention adequately
addresses patients’ communication and financial
needs in social workers’ views, and (2) ensuring the
intervention can be feasibly implemented and sus-
tained by transplant centers long-term. For instance,
we asked social workers and coordinators to identify
the resources they typically provide to patients and
families concerned about the financial aspects of
LDKT and we incorporated usual work flows regard-
ing financial support into the protocol. Further, in
our prior focus groups of patients and families con-
sidering LDKT or with LDKT experience, groups
identified additional support roles that transplant so-
cial workers would be well qualified to fill, including
a role as a point of contact for patients and families
seeking financial assistance with LDKT [14]. We re-
fined the original TALK SWI behavioral support
protocol to include these additional roles that are
routinely filled by social workers in transplant
centers. We also asked transplant program social workers,
nurse coordinators, administrators, and transplant
surgeons and nephrologists about clinical workflows
entailed with recipient and donor evaluations in an
effort to integrate interventions to complement exist-
ing clinical programs.
Live donor financial assistance intervention
We have designed a financial assistance intervention to
provide support for potential living kidney donors’ med-
ical and non-medical expenses associated with pursuing
live kidney donation. The intervention is modeled after
the National Living Donor Assistance Center (NLDAC),
a federally funded program administered by the Division
of Transplantation (DoT), Healthcare Systems Bureau
(HSB), Health Resources and Services Administration
(HRSA), United States Health and Human Services
(HHS) through a cooperative agreement with the
University of Michigan and the American Society of
Transplant Surgeons (http://www.livingdonorassistance.org/
default.aspx) [21]. It is intended to provide financial
support for potential live kidney donors in circum-
stances where existing federal programs do not pro-
vide support. We will offer patient participants the
option of enrolling their willing potential live kidney
donors (i.e. persons who may wish to pursue live kid-
ney donation) in the financial assistance program,
which will provide reimbursement for medical and
non-medical expenses related to the evaluation, sur-
gery, and recovery periods associated with live kidney
donation. Each patient participant (potential kidney
recipient) will be offered a “bank” of $2100.00 from
which potential donors can receive reimbursement for
live kidney donation related expenses. While multiple
people may step forward to be evaluated for donation
and incur expenses, the total amount available per pa-
tient participant is $2100.00. Our intervention will
provide reimbursement to a broad group of potential
donors, of which many may not meet NLDAC in-
come requirements. Participants not qualifying for
NLDAC may not require the same level of financial
reimbursement, or those choosing to forgo NLDAC
may desire more broadly applicable financial assist-
ance (e.g., for lost wages from work) than assistance
provided by NLDAC (Table 3). Based on national data
in 2010, $2100.00 corresponded to 3 weeks of paid
leave from work for production or non-supervisory
workers [26], approximately 4 weeks of child care,
[27] or travel and lodging needs for donors coming
from other geographic areas. If effective, our intervention
may provide rationale for expanding current qualification
requirements for programs such as NLDAC.
We will reimburse potential donors for approved fi-
nancial assistance through the study by submitting for-
mal original invoices, receipts, and other documentation
of their need for reimbursement of qualified medical and
non-medical expenses related to live kidney donation
evaluation, donation, or convalescence (up to one year
after the patient participant enrolls in the study). Quali-
fying expenses include travel, lodging, meals, incidental
expenses (e.g., parking, long-distance phone calls), lost
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wages, doctors and hospital visits, and childcare costs in-
curred by the potential donor as part of (1) donor evalu-
ation, clinic visit or hospitalization, (2) hospitalization
for the living donor surgical procedure, and/or (3) med-
ical or surgical follow-up clinic visit or hospitalization
within one year of the patient participant’s enrollment in
the study. Participants will be permitted to utilize the
$2100.00 for multiple approved purposes, as long as the
total value is not greater than $2100.00. Furthermore,
more than one potential donor may draw from these
funds, as the total value of reimbursed expenses does not
exceed the value of $2100.00 per patient participant.
We developed the Live Donor Financial Assistance
Intervention following guidelines of the “Organ Donation
and Recovery Improvement Act (ODRIA),” (Section 3, 42
U.S.C. 274f) signed into law on April 5, 2004, establishing
the authority and legislative parameters to provide reim-
bursement for travel and subsistence expenses incurred
towards living organ donation. The financial assistance
program being offered as part of this study is intended to
provide reimbursement only in those circumstances when
payment cannot reasonably be covered by other sources
of reimbursement, including: any State compensation pro-
gram, an insurance policy, or any Federal or State health
benefits program; an entity that provides health services
on a prepaid basis; or the recipient of the organ. In order
to be reimbursed for travel and qualifying expenses,
potential living organ donors must also meet all of the
following eligibility criteria and attest to: be a U.S. citizen
or U.S. resident; have primary residence in the U.S. or its
territories; travel is originating from the donor’s primary
residence; donor and recipient attest to full compliance
with section 301 of the National Organ Transplant Act
(NOTA), as amended (42 U.S.C. 274e) which stipulated in
part “…(i)t shall be unlawful for any person to knowingly
acquire, receive, or otherwise transfer any human organ
for valuable consideration for use in human trans-
plantation if the transfer affects interstate commerce”;
the transplant center where the donation procedure
occurs attests to its status of good standing with the
Organ Procurement and Transplantation Network.
Additionally, potential donors are eligible for reim-
bursement for qualifying expenses incurred toward
the intended donation of an organ, even if the dona-
tion does not occur.
Randomized controlled trial
We will conduct a randomized controlled trial to assess
the effectiveness of TALK SWI and the TALK SWI plus
financial assistance intervention to improve rates of
LDKT among African American potential transplant re-
cipients on the deceased donor kidney waiting list at the
Duke Kidney and Pancreas Transplant Program com-
pared to usual care (Fig. 1). We will follow potential re-
cipients for 1 year to assess live kidney donor activation
on potential recipients’ behalves (live donor inquiries,
completed new live donor evaluations, or live kidney do-
nation) (primary outcome). We will also assess potential
recipients’ self-reported behaviors reflecting their pursuit
of LDKT, including their conduct of LDKT discussions
Table 3 Live donor financial assistance intervention details and qualifying expenses
Feature Proposed intervention NLDAC
Financial assistance amount $2100 $6000
Potential donor and recipient income limits No 300 % poverty level or less
Proof of donor financial hardship required No Yes
Covers travel, hotel, parking and meal costs related to donor evaluation, surgery, and follow-up Yes Yes
Covers lost wages from work related to donor evaluation, surgery, and follow-up Yes No
Covers child care related costs related to donor evaluation, surgery, and follow-up Yes No
Fig. 1 Overview of study design and randomized controlled trial
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with physicians and with their families and their identifi-
cation of potential live donors.
Target population We will target adult African American
patients with end stage kidney disease who are listed on the
deceased donor kidney waiting list of the Duke Kidney and
Pancreas Transplant Program. The Duke Kidney and Pan-
creas Transplant Program cares for a highly diverse set of
patients with end stage kidney disease, with nearly 55 % of
the deceased donor kidney transplant waiting list com-
prised of African Americans annually. African Americans
on the deceased donor kidney waiting list at Duke Kidney
and Pancreas Transplant Program reflect the local Durham,
NC population in which 19 % have incomes below
the Federal Poverty Level [28]. The Program currently
does not have a social worker program tailored specifically
to address communication, logistical or financial barriers
to LDKT in African American potential recipients.
Screening, eligibility, and recruitment We will enroll
qualifying patients (‘patient participants’) receiving care
at the Duke Kidney and Pancreas Transplant Program,
their family members and/or friends (‘family member
participants’), and their potential donors (‘potential
donor participants’) into the study. To identify patient
participants, we will screen Duke electronic medical re-
cords to identify African American patients who are
listed on the deceased donor waiting list at the Duke
Kidney and Pancreas Transplant Program with no prior
kidney transplant, and who are aged 18 and older. We
will obtain appropriate permissions that protect patients’
privacy (i.e., HIPAA waiver) prior to all study proce-
dures. We will mail patients who are potentially eligible
to participate a recruitment letter signed by all physi-
cians and surgeons in the Duke Kidney and Pancreas
Transplant Program, accompanied by information de-
scribing the study. This letter will provide instructions
for potential participants to call or email the research
team with interest in participating or to opt-out from
participation by either returning the provided letter in
the self-addressed mailed envelope, or by calling the
telephone number provided or emailing study staff prior
to the first telephone call. Following a 14-day opt-out
period, study staff will contact potential patient partici-
pants via telephone to confirm their eligibility for par-
ticipation in the study, answer any questions, obtain
verbal consent, and complete a baseline questionnaire.
Random assignment to intervention arms will take place
immediately following completion of the baseline ques-
tionnaire while consenting patient participants are on
the telephone.
Family members or friends of enrolled patient partici-
pants (i.e. ‘family member participants’) who attend a so-
cial worker visit with patient participants will be asked
to provide written consent to participate in the study at
the time they present for the social worker visit. Any
adult family member or friend who attends will be asked
to provide written consent. Potential donor participants
interested in the Live Donor Financial Assistance Inter-
vention will only become aware of the intervention
through referrals by enrolled patient participants who
are randomly assigned to TALK SWI plus financial as-
sistance study arm (see below), who voluntarily choose
to make potential donors aware on their own accord,
without prompting from study staff or the social worker.
Potential donors will contact TALKS Study staff if they
are interested in learning more about or want to take
part in the TALKS Financial Assistance Intervention. At
that time, study staff will address any questions potential
donors may have about the intervention. If they decide
to participate, study staff will obtain verbal consent over
the phone.
Random intervention assignment
Using blind and secure allocation by computer, we will
randomly assign participants to one of three interven-
tion arms: 1) control group (“Usual Care study arm”); 2)
TALK SWI (“TALKS Program study arm”); and 3) TALK
SWI plus the Live Donor Financial Assistance Interven-
tion (“TALKS Plus Program study arm”). We will per-
form outcome and correlate assessments at baseline,
4 months, and 12 months for all patient participants fol-
lowing their enrollment in the study (Fig. 1).
Usual care Patient participants assigned to receive
Usual Care will receive care as they usually would
through the Duke Kidney and Pancreas Transplant Pro-
gram. In the Usual Care program, all patients meet with
a financial coordinator to review financial programs that
may be available to them. They also meet with a social
worker to discuss transplantation options, social sup-
port, and caregiver identification, and to address any
questions patients have about transplantation. Through
Usual Care, potential donors have the option of meeting
with an external Independent Living Donor Advocate, to
address any questions or concerns they have about the
donation process.
Intervention groups Study staff will mail the TALK
video and booklet to patient participants randomly
assigned to the TALKS Program and TALKS Plus Pro-
gram study arms. A letter accompanying the video and
booklet will encourage patient participants to review the
20-min TALK video and booklet and to attend meetings
with a study social worker to receive the TALK SWI.
The letter will also encourage patient participants to
share materials with family members or friends over the
age of 18, if they desire. We will invite patient
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participants assigned to the TALKS Program and TALKS
Plus Program study arms to meet with a study social
worker for up to an hour to discuss their self-identified
barriers to LDKT and strategies to overcome barriers.
Following this initial meeting, the social worker will in-
vite patient participants to participate in a second ses-
sion to discuss possible pursuit of LDKT by themselves
or with one or more adult family members or friends.
TALK social worker visits occur outside of the usual
care setting.
If patient participants are randomly assigned to the
TALKS Plus Program study arm, study staff will also
mail information about the live donor financial assistance
intervention along with the TALK video and booklet. Study
staff will review the TALKS Study Financial Assistance
Intervention with patient participants assigned to this arm
at their first visit with the study social worker.
Participant reimbursements
Patient participants will receive $30 for completing each
of the questionnaires and $50 for each completed ses-
sion with the social worker. Family participants attend-
ing social worker meetings will receive $20 total for
completing the questionnaire and for participating in the
social worker session. Potential donors identified by
patient participants in the TALKS Plus Program study
arm who want to participate in the Live Donor Financial
Assistance Intervention will be asked to complete a Live
Donor Financial Assistance Intervention Donor Worksheet
summarizing expenses as well as sign a Donor Attest-
ation Form to confirm that they understand the legal
restrictions of the intervention. Study staff will mail
potential donors checks reimbursing approved eligible
expenses.
Data collection and outcomes
Participant characteristics, correlates of LDKT, and
social worker meeting content We will collect infor-
mation on participant demographics (e.g., age, race, edu-
cation and income), attitudes/perceptions (e.g., trust in
health care team, satisfaction with transplant care), self-
reported medical history, and other correlates of LDKT
(e.g., health literacy, family function, and self-efficacy
with regard to decision-making about LDKT) via tele-
phone questionnaires performed at enrollment, 4 months,
and 12 months follow up. In addition to these correlates,
we will assess patient participants’ perceptions of the cul-
tural competency of the DKPTP and transplant social
workers using the Agency for Health Care Research and
Quality CAHPS Cultural Competence Item Set [29], de-
signed to capture patients’ perspectives on the cultural
competence of health care providers. Items include infor-
mation on patient participants’ (a) perceived communica-
tion with their transplant health care providers including
shared decision-making; (b) experiences of discrimination
due to race, ethnicity, insurance, or language; (c) experi-
ences leading to trust or distrust; (d) and linguistic compe-
tency (Table 4).
In telephone questionnaires administered at 4 months
and 12 months follow up, we will ask patient partici-
pants randomly assigned to receive TALKS interventions
whether they have reviewed the TALK video and booklet
and/or shared them with family members. We will also
ask patient participants about their perceptions of the
video and booklet. We will ask patient and family mem-
ber participants who attend the social worker meetings
their perceptions of the usefulness of these meetings at
meeting conclusion via written questionnaire. With par-
ticipant consent, we will audio record all social worker
meetings to assess content and fidelity to the interven-
tion. Social workers will also take notes to document the
content of social worker meetings in electronic case re-
port forms. For patient participants randomly assigned
to the TALKS Plus Program study arm, we will assess
via questionnaire whether patient participants made
others (e.g., family members or friends) aware of their
participation in the Live Donor Financial Assistance
Intervention. For potential donor participants, we will
assess the types of expenditures for which they request
reimbursement (Table 4).
Primary and secondary outcomes For our primary out-
come, we will assess “live kidney donor activation”,
defined as the composite rate of live kidney donor in-
quiries on behalf of patient participants, completed live
kidney donor transplant evaluations, and live kidney
donor transplants in each arm, ascertained via medical
records maintained by the Duke Kidney and Pancreas
Transplant Program. Secondarily, we will measure pa-
tient participants’ behaviors reflecting their interest and
pursuit of LDKT, including: self-reported LDKT discus-
sions with physicians, self-reported LDKT discussions
with family, and identification of a potential live donor.
We will also record if and when deceased donor trans-
plant occurs.
Analysis
Our primary analyses will test whether the TALKS
Program is more effective than usual care and whether
TALKS plus the Financial Assistance Intervention
(TALKS Plus Program) has additional incremental ef-
fectiveness compared to the TALKS Program only. We
will assess outcomes at 4 months and 12 months after
the intervention, enhancing opportunities to ascertain
patient participants’ achievement of main outcomes in
the event of patient participant attrition or missing data
due to missed study visits (e.g., due to hospitalization
with ESRD related illness).
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The primary outcome is live kidney donor activation
(i.e., live donor inquiries to transplantation, completed
live donor evaluations, or live donor kidney transplant-
ation). The primary testing contrasts are (1) TALKS
Program versus Usual Care, and (2) TALKS Plus Program
versus TALKS Program. In secondary analyses, we will
test for a trend in effectiveness (TALKS Plus Program
more effective than TALKS Program, which is in turn
more effective than Usual Care). For the primary testing
contrasts, randomly assigned intervention group (i.e.,
Usual Care, TALKS Program, TALKS Plus Program) will
be the main independent variable. For each analysis we
Table 4 Study outcomes and assessments
Baseline 4 months 12 months
Primary outcome: Live kidney donor activation (Composite)
Live donor kidney transplantation (LDKT) X X
Completed live donor evaluations X X X
Live donor inquiries to transplant center X X X
Secondary outcomes
LDKT discussions with physician X X X
LDKT discussions with family and/or friends X X X
Identification of potential live donor X X X
Belief & knowledge about treatment for kidney failure, interest in LDKT
Beliefs about treatment for kidney failure X X X
Knowledge of LDKT X X X
Interest in and concerns about LDKT X X X
Knowledge of kidney transplant financial assistance programs X X X
Barriers to and quality of family discussion about LDKT X X X
Mediators and correlates of pursuit of LDKT
Current treatment information X X X
Socio-demographic Information X
Family wealtha X
Family function (Family APGAR Scale) [32] X
Decision self-efficacy about LDKT [33] X X X
Decisional conflict scale [34] X X X
Trust in medical care [35, 36] X
Barriers to obtaining information about LDKT X X
Depressed mood (PRIME-MD) [37] X X X
Social health (PROMIS-SF) [38, 39] X X X
Risk numeracy [40, 41] X
Rapid Estimate of Adult Literacy in Medicine (REALM) [42] X
Personal financial well-being scalea [43] X
Patient assessment of providers and systems
Cultural competence of health care providers [29] X X X
In-center dialysis care [44] X X X
Nephrologists’ communication and caring X X X
Fidelity to TALK SWI protocol, intervention uptake and satisfaction
Participant use of TALK SWI educational materials X X
Participant satisfaction with TALK SWI sessionsa X
Transplant social worker adherence to TALK SWI protocol X X
Use of financial assistance programs (by donors) and types of expenditures reimbursed X X
aInformation is provided by patient participants and family member participants
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will use chi-square statistics to assess the proportion of
participants in each group achieving at least one live
donor activation outcome over 12 months. In the circum-
stance that there is imbalance in baseline characteristics
between the two groups, we will use multivariable analyses
to assess differences in live donor activation (dependent
variable) over 12 months accounting for group differences.
We will account for multiple comparisons (2 primary
comparisons). We will assess the prevalence of missing
data and examine robustness of intervention effects under
various assumptions regarding plausible patterns of miss-
ing data in sensitivity analyses.
Sample size estimates
We will enroll and randomly assign 100 patient partici-
pants per study arm. Few randomized controlled trials
have been previously performed to establish the effect-
iveness of interventions to improve rates of live kidney
donation and LDKT among African Americans. In our
own TALK study among chronic kidney disease patients,
we identified a 28 % improvement in achievement of
LDKT consideration/pursuit behaviors at 6 months. In
another randomized controlled trial, home visits to Afri-
can American families led to a 20 % improvement in live
donor inquiries [30]. Based on these studies, we estimate
the TALKS interventions will yield a 25 % improvement
in live donor activation behaviors. We are not aware of
studies directly studying the effect of financial interven-
tions on live donor activation. We expect that potentially
willing donors will be enthusiastic about participating in
this intervention and estimate at least an additional 20 %
incremental increase in live donor activation with the fi-
nancial assistance intervention. Under usual circum-
stances, we estimate approximately 25 % of African
American patients in the Duke Kidney and Pancreas
Transplant Program deceased donor transplant waiting
list receive inquiries from live donors interested in being
evaluated on waiting list registrants’ behalves each year.
Under these assumptions, we estimate we will have ap-
proximately 95 % power to detect a 23-30 % differ-
ence between TALKS Program study arm and Usual
Care study arm at follow up as well as a 21-25 % differ-
ence between TALKS Plus Program study arm and the
TALKS Program study arm at follow-up. We also estimate
we will have 99 % power to observe a trend across the
intervention arms, while accounting for multiple compari-
sons, and accounting for 80 % attrition of participants.
Discussion
Interventions to improve African Americans’ access to
LDKT are sorely needed, as trends indicate few reduc-
tions in disparities in receipt of LDKT have been made
over the past 10 years [31]. African American patients
on the live donor kidney transplant waiting list are likely
to be highly motivated to receive transplants and have
already overcome some barriers to receiving a transplant
by completing their recipient transplant evaluations.
Nonetheless, they may not have completed key steps to
receiving LDKT, contributing to disparities in their ac-
cess to this optimal treatment. TALK interventions are
designed to be culturally sensitive and to directly target
barriers to LDKT previously identified as important to
African Americans, but they have not yet been tested
among African American patients on the deceased
donor kidney waiting list. The Live Donor Financial
Assistance Intervention extends TALK interventions by
additionally addressing potential donor logistical and fi-
nancial barriers to LDKT.
To our knowledge, TALKS will be one of the first Na-
tional Institutes of Health (NIH) funded studies to evalu-
ate the effectiveness of combining educational and
behavioral interventions with live donor financial assist-
ance to help African Americans on the waiting list
receive LDKT. In addition to providing valuable infor-
mation on the incremental effectiveness of the live
donor financial assistance intervention to improve access
to LDKT, information we obtain on the types of expen-
ditures potential donors seek for reimbursement will
broaden our understanding of the types of assistance
which potential donors need the most. Evidence on the
uptake and effectiveness of the financial assistance inter-
vention will help inform current national and regional
program resource allocation as well as the need and/or
feasibility of expanding current programs.
As one of few clinical trials in the field, the TALKS
Study will provide needed rigorous evidence to identify
practical and effective strategies to improve disparities in
LDKT. If TALKS interventions are effective, their ultim-
ate translation into clinical practice changes will be re-
quired to yield substantive and lasting improvements in
LDKT rates among African Americans.
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